Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Kresinsky

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|December 26, 2023
CRISPR/Cas9-Mediated Modification of PTP ExpressionCarolin Lossius, Anne Kresinsky, Laura Quiet, et al.
Frontiers in Oncology|December 1, 2022
Disrupting PTPRJ transmembrane-mediated oligomerization counteracts oncogenic receptor tyrosine kinase FLT3 ITDMarie Schwarz, Sophie Rizzo, Walter Espinoza Paz, et al.
Immunology Letters|October 11, 2016
Phagocytosis of bone marrow derived macrophages is controlled by phosphoinositide 3-kinase γAnne Kresinsky, Nadine Schneble, Caroline Schmidt, et al.
Antioxidants (Basel, Switzerland)|March 25, 2022
Combined Activity of the Redox-Modulating Compound Setanaxib (GKT137831) with Cytotoxic Agents in the Killing of Acute Myeloid Leukemia CellsMuhammed Burak Demircan, Peter C Mgbecheta, Anne Kresinsky, et al.
Oncotarget|March 7, 2018
PTPRG and PTPRC modulate nilotinib response in chronic myeloid leukemia cellsJulia Drube, Thomas Ernst, Markus Pfirrmann, et al.
Oncogene|March 2, 2019
Lack of CD45 in FLT3-ITD mice results in a myeloproliferative phenotype, cortical porosity, and ectopic bone formationAnne Kresinsky, Tina M Schnöder, Ilse D Jacobsen, et al.
Leukemia|October 3, 2019
The acetyltransferase GCN5 maintains ATRA-resistance in non-APL AMLMelanie Kahl, Annamaria Brioli, Martin Bens, et al.
Leukemia|January 18, 2020
Correction: The acetyltransferase GCN5 maintains ATRA-resistance in non-APL AMLMelanie Kahl, Annamaria Brioli, Martin Bens, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|December 26, 2023
CRISPR/Cas9-Mediated Modification of PTP ExpressionCarolin Lossius, Anne Kresinsky, Laura Quiet, et al.
Frontiers in Oncology|December 1, 2022
Disrupting PTPRJ transmembrane-mediated oligomerization counteracts oncogenic receptor tyrosine kinase FLT3 ITDMarie Schwarz, Sophie Rizzo, Walter Espinoza Paz, et al.
Immunology Letters|October 11, 2016
Phagocytosis of bone marrow derived macrophages is controlled by phosphoinositide 3-kinase γAnne Kresinsky, Nadine Schneble, Caroline Schmidt, et al.
Antioxidants (Basel, Switzerland)|March 25, 2022
Combined Activity of the Redox-Modulating Compound Setanaxib (GKT137831) with Cytotoxic Agents in the Killing of Acute Myeloid Leukemia CellsMuhammed Burak Demircan, Peter C Mgbecheta, Anne Kresinsky, et al.
Oncotarget|March 7, 2018
PTPRG and PTPRC modulate nilotinib response in chronic myeloid leukemia cellsJulia Drube, Thomas Ernst, Markus Pfirrmann, et al.
Oncogene|March 2, 2019
Lack of CD45 in FLT3-ITD mice results in a myeloproliferative phenotype, cortical porosity, and ectopic bone formationAnne Kresinsky, Tina M Schnöder, Ilse D Jacobsen, et al.
Leukemia|October 3, 2019
The acetyltransferase GCN5 maintains ATRA-resistance in non-APL AMLMelanie Kahl, Annamaria Brioli, Martin Bens, et al.
Leukemia|January 18, 2020
Correction: The acetyltransferase GCN5 maintains ATRA-resistance in non-APL AMLMelanie Kahl, Annamaria Brioli, Martin Bens, et al.
Pageof 1